RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Kyorin Pharmaceutical Co Stock

Kyorin Pharmaceutical Co ROA 2024

Kyorin Pharmaceutical Co ROA

0.03

Ticker

4569.T

ISIN

JP3247090008

In 2024, Kyorin Pharmaceutical Co's return on assets (ROA) was 0.03, a 30.97% increase from the 0.02 ROA in the previous year.

Kyorin Pharmaceutical Co Aktienanalyse

What does Kyorin Pharmaceutical Co do?

Kyorin Holdings Inc is a Japanese holding company that was founded in September 2007. However, the company's history dates back to 1947 when Kyorin Pharmaceutical Co., Ltd. was established. Kyorin Holdings is a diversified company that operates in various sectors and business areas. The company's main activities include the development, production, and marketing of pharmaceutical products, medical devices, and healthcare products. In the pharmaceutical sector, Kyorin has been active since its inception. The company offers a wide range of products for various conditions such as asthma, allergies, or diabetes. Additionally, Kyorin is dedicated to developing medications for rarer diseases such as Fabry disease or amyotrophic lateral sclerosis (ALS). Another important business area of Kyorin is medical devices and accessories. The company primarily focuses on devices for the diagnosis and treatment of respiratory diseases and allergies. This includes inhalers, peak flow meters, and allergy tests. Healthcare is another significant business area of Kyorin Holdings. The company offers products for maintaining and strengthening the immune system, such as dietary supplements and probiotics. Kyorin also provides cosmetic products made from plant-based ingredients. One of Kyorin's current projects is the development of peptide-based immunotherapies for cancer. The company has already achieved promising results in preclinical research and plans to continue clinical trials in the coming years. The corporate philosophy of Kyorin emphasizes the importance of research and development. The company invests a significant portion of its annual revenue in research and development and strives to find innovative solutions for disease treatment. Kyorin also values collaboration with other companies and research institutions. The company has formed partnerships with other pharmaceutical and medical technology companies to work together on the research and development of new products. Kyorin Holdings Inc is a company that focuses on the development and marketing of products that contribute to improving health and well-being. The company's various business areas allow it to target different audiences and meet the needs of patients and customers in various fields. With its long-standing experience in the pharmaceutical and medical technology sectors and its commitment to innovation and research, Kyorin remains an important player in healthcare and is dedicated to improving the quality of life for people worldwide. Kyorin Pharmaceutical Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROA Details

Understanding Kyorin Pharmaceutical Co's Return on Assets (ROA)

Kyorin Pharmaceutical Co's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Kyorin Pharmaceutical Co's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Kyorin Pharmaceutical Co's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Kyorin Pharmaceutical Co’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Kyorin Pharmaceutical Co stock

What is the Return on Assets (ROA) of Kyorin Pharmaceutical Co this year?

The Return on Assets (ROA) of Kyorin Pharmaceutical Co is 0.03 undefined this year.

What was the ROA of Kyorin Pharmaceutical Co compared to the previous year?

The ROA of Kyorin Pharmaceutical Co has increased by 30.97% compared to the previous year.

What consequences do high ROA have for investors of Kyorin Pharmaceutical Co?

A high ROA is advantageous for investors of Kyorin Pharmaceutical Co, as it indicates that the company efficiently utilizes its assets and generates good profits.

What are the consequences of low ROA for investors in Kyorin Pharmaceutical Co?

A low ROA can be unfavorable for investors of Kyorin Pharmaceutical Co as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.

How does an increase in the ROA of Kyorin Pharmaceutical Co affect the company?

An increase in ROA of Kyorin Pharmaceutical Co can be an indicator of improved efficiency in asset utilization and higher profitability.

How does a reduction in ROA of Kyorin Pharmaceutical Co impact the company?

A reduction in the ROA of Kyorin Pharmaceutical Co can be an indicator of lower asset efficiency and profitability.

What are some factors that can influence the ROA of Kyorin Pharmaceutical Co?

Some factors that can influence the ROA of Kyorin Pharmaceutical Co include revenue, operating costs, asset structure, and industry average.

Why is the ROA of Kyorin Pharmaceutical Co important for investors?

The ROA of Kyorin Pharmaceutical Co is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.

What strategic measures can Kyorin Pharmaceutical Co take to improve ROA?

To improve ROA, Kyorin Pharmaceutical Co can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.

How much dividend does Kyorin Pharmaceutical Co pay?

Over the past 12 months, Kyorin Pharmaceutical Co paid a dividend of 52 JPY . This corresponds to a dividend yield of about 3.26 %. For the coming 12 months, Kyorin Pharmaceutical Co is expected to pay a dividend of 52.48 JPY.

What is the dividend yield of Kyorin Pharmaceutical Co?

The current dividend yield of Kyorin Pharmaceutical Co is 3.26 %.

When does Kyorin Pharmaceutical Co pay dividends?

Kyorin Pharmaceutical Co pays a quarterly dividend. This is distributed in the months of October, April, October, April.

How secure is the dividend of Kyorin Pharmaceutical Co?

Kyorin Pharmaceutical Co paid dividends every year for the past 22 years.

What is the dividend of Kyorin Pharmaceutical Co?

For the upcoming 12 months, dividends amounting to 52.48 JPY are expected. This corresponds to a dividend yield of 3.29 %.

In which sector is Kyorin Pharmaceutical Co located?

Kyorin Pharmaceutical Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Kyorin Pharmaceutical Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Kyorin Pharmaceutical Co from 12/1/2024 amounting to 20 JPY, you needed to have the stock in your portfolio before the ex-date on 9/27/2024.

When did Kyorin Pharmaceutical Co pay the last dividend?

The last dividend was paid out on 12/1/2024.

What was the dividend of Kyorin Pharmaceutical Co in the year 2023?

In the year 2023, Kyorin Pharmaceutical Co distributed 52 JPY as dividends.

In which currency does Kyorin Pharmaceutical Co pay out the dividend?

The dividends of Kyorin Pharmaceutical Co are distributed in JPY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Kyorin Pharmaceutical Co

Our stock analysis for Kyorin Pharmaceutical Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Kyorin Pharmaceutical Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.